EJ Kuiper, FA Van Nieuwenhoven, MD de … - PLoS One, 2008 - pubmedcentral.nih.gov Conceived and designed the experiments: EJK RG ROS. Performed the experiments:
EJK. Analyzed the data: MWT. Contributed reagents/materials/analysis tools: MDD
JCV. Wrote the paper: EJK ROS. Overall responsibility for the coordination ... Cited by 8 - Related articles - All 7 versions
- ►pnas.org T Kita, Y Hata, R Arita, S Kawahara, M Miura … - Proceedings of the National Academy of Sciences, 2008 - National Acad Sciences Cicatricial contraction of preretinal fibrous membrane is a cause of severe
vision loss in proliferative vitreoretinal diseases such as proliferative
diabetic retinopathy (PDR) and proliferative vitreoretinopathy (PVR). ... Cited by 5 - Related articles - All 6 versions
- ►iovs.org S He, Y Chen, R Khankan, E Barron, R Burton … - Investigative ophthalmology & visual science, 2008 - ARVO METHODS. Expression of CTGF was evaluated immunohistochemically in human PVR
membranes, and the accumulation of CTGF in the vitreous was evaluated by ELISA.
The effects of CTGF on type I collagen mRNA and protein expression in RPE ... Cited by 4 - Related articles - All 4 versions
K Kifuku, Y Hata, R Kohno, S Kawahara, Y … - British Journal of Ophthalmology, 2009 - bjo.bmj.com Methods: Sixty-one eyes of 59 patients with ERM were enrolled. After ERM
peeling, residual ILM was visualised with Brilliant Blue G (BBG). The residual
ILM pattern was divided into three groups: (1) residual type (ILM mostly ... Cited by 2 - Related articles - All 3 versions
CM Guo, YS Wang, D Hu, QH Han, JB Wang, … - Current Eye Research, 2009 - informahealthcare.com Results: The CTGF expression first increased after being wounded in RPE cells,
then reached a peak and maintained at a high level. The positive expression was
mainly at the edge of scrape and in motile RPE cells. rhCTGF-stimulated RPE ...
N Tojo, Y Kashiwagi, K Nishitsuka, S … - Acta Ophthalmologica, 2009 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Related articles - All 2 versions
H Lei, G Velez, P Hovland, T Hirose, D … - Investigative Ophthalmology & Visual Science, 2009 - ARVO PURPOSE. Proliferative vitreoretinopathy (PVR) is a recurring and problematic
disease for which there is no pharmacologic treatment. Platelet-derived growth
factor (PDGF) in the vitreous is associated with experimental and clinical ... Related articles - All 3 versions
M Surgery - bjo.bmj.com Page 1. doi: 10.1136/bjo.2008.150623 published online February 11, 2009 Br J
Ophthalmol Kaori Kifuku, yasuaki Hata, Ri-ichiro Kohno, et al. ... Related articles
HLA Kazlauskas - Journal of Biological Chemistry - ASBMB The vitreous contains a plethora of growth factors that are strongly implicated
in the formation of fibroproliferative diseases such as proliferative
vitreoretinopathy (PVR). We previously reported that while platelet-derived ... Related articles
H Lei, A Kazlauskas - Journal of Biological Chemistry, 2009 - ASBMB The vitreous contains a plethora of growth factors that are strongly implicated
in the formation of fibroproliferative diseases such as proliferative
vitreoretinopathy. Although platelet-derived growth factors (PDGFs) are ... Related articles - All 2 versions